CAMP
CAMP4 THERAPEUTICS CORPORATIONNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$234.19M
P/E Ratio
—
EPS
$-2.35
Beta
—
52W High
$7.75
52W Low
$1.30
50-Day MA
$4.52
200-Day MA
$4.01
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About CAMP4 THERAPEUTICS CORPORATION
CalAmp Corp. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $3.93M |
| Gross Profit (TTM) | $-34.27M |
| EBITDA | $-50.29M |
| Operating Margin | -1010.00% |
| Return on Equity | -209.30% |
| Return on Assets | -38.70% |
| Revenue/Share (TTM) | $0.10 |
| Book Value | $0.59 |
| Price-to-Book | 7.56 |
| Price-to-Sales (TTM) | 59.53 |
| EV/Revenue | 34.72 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 50.80% |
| Shares Outstanding | $51.93M |
| Float | $29.22M |
| % Insiders | 13.07% |
| % Institutions | 86.62% |
Analyst Ratings
Consensus ($8.20 target)
1
Strong Buy4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026